Yongjiang Li

6.3k total citations · 4 hit papers
141 papers, 4.5k citations indexed

About

Yongjiang Li is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Yongjiang Li has authored 141 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 30 papers in Biomedical Engineering and 19 papers in Oncology. Recurrent topics in Yongjiang Li's work include RNA Interference and Gene Delivery (20 papers), Nanoplatforms for cancer theranostics (19 papers) and Extracellular vesicles in disease (17 papers). Yongjiang Li is often cited by papers focused on RNA Interference and Gene Delivery (20 papers), Nanoplatforms for cancer theranostics (19 papers) and Extracellular vesicles in disease (17 papers). Yongjiang Li collaborates with scholars based in China, United States and Australia. Yongjiang Li's co-authors include Junyong Wu, Daxiong Xiang, Xiong-Bin Hu, Jiemin Wang, Si Huang, Wei Tao, Wenjie Xu, Jiaxin Cai, Xiaohua Wu and Lan N. Truong and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Yongjiang Li

134 papers receiving 4.5k citations

Hit Papers

Artificial exosomes for translational nanomedicine 2021 2026 2022 2024 2021 2023 2023 2024 50 100 150 200 250

Peers

Yongjiang Li
Jian‐Liang Li United States
Jing Xie China
Yuan Wang China
Wei Lei China
Yi Jin China
Jian‐Liang Li United States
Yongjiang Li
Citations per year, relative to Yongjiang Li Yongjiang Li (= 1×) peers Jian‐Liang Li

Countries citing papers authored by Yongjiang Li

Since Specialization
Citations

This map shows the geographic impact of Yongjiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjiang Li more than expected).

Fields of papers citing papers by Yongjiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjiang Li. The network helps show where Yongjiang Li may publish in the future.

Co-authorship network of co-authors of Yongjiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjiang Li. A scholar is included among the top collaborators of Yongjiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjiang Li. Yongjiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yongjiang, Zhuoming Zhou, Qimanguli Saiding, et al.. (2025). Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy. Science Advances. 11(21). eadw7191–eadw7191. 6 indexed citations
2.
Huang, Xiangang, Chuang LIU, Xinru You, et al.. (2025). Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease. Science Translational Medicine. 17(807). eadu1493–eadu1493. 3 indexed citations
3.
Duan, Zhong-Hui, Bin Su, Yongjiang Li, et al.. (2025). IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis. Circulation. 152(22). 1564–1581.
4.
Li, Yongjiang, Ailing Zhang, Yanhui Wang, et al.. (2025). Synergistic flame-retardant action of Fe/Co/Cu-diphenylphosphonic acid coordination compounds in flexible polyurethane foam: A mechanistic study. Polymer Degradation and Stability. 244. 111834–111834.
5.
Li, Yongjiang, Zheng Liu, Chun‐Dong Xue, et al.. (2025). Adjusting blood redistribution to suppress flow disturbances of hemodialysis arteriovenous fistula: a computational fluid dynamics analysis. Frontiers in Bioengineering and Biotechnology. 13. 1551993–1551993.
6.
Zhang, Yuyuan, et al.. (2024). Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms. Frontiers in Endocrinology. 15. 1396022–1396022. 8 indexed citations
7.
Xiao, Yufen, Zhongmin Tang, Qimanguli Saiding, et al.. (2024). One-Pot Synthesis of Fe-Norepinephrine Nanoparticles for Synergetic Thermal-Enhanced Chemodynamic Therapy. Nano Letters. 24(43). 13825–13833. 3 indexed citations
8.
Zhen, Xueyan, Yongjiang Li, Tingting Zhang, et al.. (2024). Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment. Advanced Materials. 36(41). e2401495–e2401495. 40 indexed citations
9.
Yu, Ronghua, Xin Wen, Yue Zhu, et al.. (2023). Boron-doped copper phenylphosphate as temperature-response nanosheets to fabricate high fire-safety polycarbonate nanocomposites. Composites Part A Applied Science and Manufacturing. 175. 107812–107812. 16 indexed citations
10.
Nie, Yichu, Wei Chen, Yong Kang, et al.. (2023). Two-dimensional porous vermiculite-based nanocatalysts for synergetic catalytic therapy. Biomaterials. 295. 122031–122031. 44 indexed citations
11.
Li, Yongjiang, Juan Wang, Junfeng Hu, et al.. (2023). PET/CT scan without sedation: how to use total-body PET/CT to salvage child’s involuntary movement?. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2912–2913. 13 indexed citations
12.
Cai, Jiaxin, Jihua Liu, Junyong Wu, et al.. (2022). Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma. SHILAP Revista de lepidopterología. 48 indexed citations
13.
Dai, Wei, et al.. (2020). Network Embedding the Protein–Protein Interaction Network for Human Essential Genes Identification. Genes. 11(2). 153–153. 24 indexed citations
14.
Wu, Junyong, Anyao Bi, Fan Zheng, et al.. (2020). Wash-free 3D imaging and detection of glioma with a novel neuropotential targeted AIE probe. Chemical Communications. 57(6). 801–804. 10 indexed citations
16.
Li, Yongjiang, Junyong Wu, Jiemin Wang, & Daxiong Xiang. (2020). Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer. Journal of Controlled Release. 320. 105–111. 32 indexed citations
17.
Li, Yongjiang, Xiaojie Zhang, & Yamin Li. (2019). Antineuroinflammatory therapy: potential treatment for autism spectrum disorder by inhibiting glial activation and restoring synaptic function. CNS Spectrums. 25(4). 493–501. 23 indexed citations
18.
Wu, Junyong, Yongjiang Li, Xin-Yi Liu, et al.. (2019). <p>3,5,4′-trimethoxy-trans-stilbene loaded PEG-PE micelles for the treatment of colon cancer</p>. International Journal of Nanomedicine. Volume 14. 7489–7502. 10 indexed citations
19.
Sun, Lei, Yongjiang Li, Xi Yang, Ling Gao, & Yi Cheng. (2017). Effect of fasting therapy in chemotherapy-protection and tumorsuppression: a systematic review. Translational Cancer Research. 6(2). 354–365. 3 indexed citations
20.
Li, Yongjiang, et al.. (2016). Osteosarcoma at the site of a previously treated simple bone cyst. Translational Cancer Research. 5(6). 877–882.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026